Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Ipriflavone

Ipriflavone

pharmaceutical raw materials
Ipriflavone structure

Ipriflavone 

structure
  • CAS No:

    35212-22-7

  • Formula:

    C18H16O3

  • Chemical Name:

    Ipriflavone

  • Synonyms:

    4H-1-Benzopyran-4-one,7-(1-methylethoxy)-3-phenyl-;7-(1-Methylethoxy)-3-phenyl-4H-1-benzopyran-4-one;7-Isopropoxyisoflavone;Ipriflavone;FL 113;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;TC 80;Osteofix;Osteofix (pharmaceutical);Osten;Yambolap;Iprosten;TC 80 (pharmaceutical);Iprivone;3-Phenyl-7-propan-2-yloxychromen-4-one

  • Categories:

    Active Pharmaceutical Ingredients  >  Fluid, Electrolyte, and Acid-base Balance

Description

Ipriflavone is a synthetic isoflavone derivative used to suppress bone resorption.


Solid


Ipriflavone is a member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women. It has a role as a bone density conservation agent. It is a member of isoflavones and an aromatic ether.

Ipriflavone Basic Attributes

280.32

280.32

201-641-0

80BJ7WN25Z

DTXSID5040679

M - Musculo-skeletal system

2914509090

Characteristics

35.5

4

Solid

1.2±0.1 g/cm3

115-117 °C

435.9°C at 760 mmHg

209.3±15.1 °C

1.592

2.301 mg/L @ 25 °C (est)

Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

164.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

2

36/37/38

24/25-36/37/39-27-26

DJ3100500

Xi

Drug Information

Ipriflavone has known human metabolites that include 3-Phenyl-7-(1-methyl-2-hydroxyethoxy)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-(1-methylethoxy)-, and 7-Hydroxyisoflavone.

7-isopropoxyisoflavone

Ipriflavone Use and Manufacturing

Methods of Manufacturing

To a solution of 2.50 g of analog 1 (10.5 mmol) in 30 ml of DMF was added 1.80 g of anhydrous IL2CO3 (13.0 mmol) and 3.0 ml of 2-bromopropane (32.0 mmol). The mixture was stirred at 80 °C for 4 hours and then poured into ice water. Precipitates were collected by filtration, washed with small portions of water, and dried to give a residue of crude product. The residue was loaded onto a Sephadex LH-20 column (chloroform : methanol, 7: 3) and fractions that contained pure product were pooled, concentrated, and recrystallized from acetone to give 1.05 g of crystalline analog 5, a yield of 42 percent (w/w): mp 110-111 °C. 1H NMR (DMSO-d6) 8 1.33 (-CH3), 1.34 (-CH3), 4.86 (m, 1H, >CH2-), 7.05 (dd, 1H, J= 8. 86, 2.20 Hz, 6-H), 7.16 (d, 1H, J= 2. 50 Hz, 8H), 7.38 (t, 1H, J= 6.78 Hz, 4'-H), 7.44 (t, 2H, J= 7.76, 1.6 Hz, 3', 5'-H), 7.59 (d, 2H, J= 8.09, 1.6 Hz, 2', 6'-H), 8. 02 (d, IH, J= 8. 86 Hz, 5-H), 8. 46 (s, 1H, 2-H). 13C NMR (DMSO-d6) 8 21.5 (-CH3), 21.5 (-CH3), 70.4 (-CH2-O-), 101. 8 (C-8), 115.7 (C-6), 117.3 (C-10), 123.7 (C-3), 127.0 (C-1'), 127.8 (C-5), 128.1 (C-3', 5'), 128.9 (C-2', 6'), 132.0 (C4'), 154.0 (C-2), 157.5 (C-9), 162.0 (C-7), 174.1 (C-4). MS (m/z) 281.4 (M + H) +, 303. 3 (M + Na) +, 319.4 (M + K) +, 279.5 (M-H)-. Anal. (C23H2405) for C, H. Cacld : 77.12, 5.75 ; found: 76.50, 5.69.

Uses

anabolic It acts directly on the bone, inhibits bone resorption, and increases the secretion of calciferin through estrogen. Used for osteoporosis and bone loss. Hormonal drugs.

Computed Properties

Molecular Weight:280.3
XLogP3:4
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:280.109944368
Monoisotopic Mass:280.109944368
Topological Polar Surface Area:35.5
Heavy Atom Count:21
Complexity:407
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

It is used to improve osteoporosis-induced bone loss, and has an inhibitory effect on experimental osteoporosis rats caused by ovariectomy and prednisolone. Its mechanism of action includes: directly inhibiting bone resorption; increasing the secretion of calcitonin through estrogen-like effects, indirectly producing an anti-bone resorption effect; and promoting bone formation.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Chifeng Arker Pharmaceutical Technology Co., Ltd.

    China China
    Active
  • Hubei Sihuan Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Ipriflavone

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.